Does the Vaccination against Tick-Borne Encephalitis Offer Good Value for Money for Incidence Rates below the WHO Threshold for Endemicity? A Case Study for Germany

This journal publication offers insights into the following topics:

– Access to TBE vaccination relies on decisions made by national or local authorities, which consider both recommendations and funding. 
– The research demonstrates that vaccination remains a cost-effective preventive measure, even in regions with lower incidence rates.
– It highlights the potential to avoid severe TBE cases and reduce the burden of illness, offering valuable insights for policymakers assessing vaccination strategies in these regions.